ArticleOral and maxillofacial surgery2026
Continuous administration of heparin during free flap surgery for head and neck tumors reduces the risk of pulmonary embolism.
Article in Oral and maxillofacial surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study investigated the impact of different anticoagulation protocols on the incidence of pulmonary embolism (PE) in patients with head and neck tumors who underwent microvascular flap reconstruction.
methodsWe conducted a retrospective case‒control analysis of 92 patients. Two anticoagulation strategies were evaluated: one group received 10000 IU of unfractionated heparin (UFH) administered over 24 hours (h) starting 6 h postoperatively for one week.The other group received 3 IU of UFH per kilogram of total body weight per h at the onset of surgery until 6 h after surgery. The activated partial thromboplastin time (aPTT) target was subsequently set at 50 to 60 seconds for one week.
resultsThe group that received intraoperative UFH presented a significantly lower incidence of PE (6.5% compared with 17.4% in the group that received 10,000 IU of UFH 6 h postoperatively), independent of the type of flap used for reconstruction. This effect was particularly notable in patients who received a forearm flap for reconstruction. There was no statistically significant difference in the incidence of bleeding requiring intervention between the two groups; however, a trend was noted, as postoperative bleeding occurred more frequently in the group receiving intraoperative heparinization.
conclusionsOur findings suggest that the intraoperative administration of UFH is effective in significantly reducing the risk of PE in patients with head and neck tumors undergoing free flap reconstruction. These results highlight the need for further research to optimize anticoagulation protocols that effectively balance thromboembolic prevention and the risk of bleeding complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.